599 related articles for article (PubMed ID: 34406626)
21. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis.
Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687
[TBL] [Abstract][Full Text] [Related]
22. Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.
Jen GH; Yen AM; Hsu CY; Chiu HM; Chen SL; Chen TH
Prev Med; 2021 Oct; 151():106597. PubMed ID: 34217416
[TBL] [Abstract][Full Text] [Related]
23. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
24. Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation.
Hijos-Mallada G; Alfaro E; Navarro M; Cañamares P; Ariño I; Charro M; Bruno C; Solano M; Pardillos A; Jimeno C; Carrera-Lasfuentes P; Lanas A; Domper-Arnal MJ
Gastroenterol Hepatol; 2023 Nov; 46(9):702-709. PubMed ID: 36716926
[TBL] [Abstract][Full Text] [Related]
25. Impact of COVID-19 Pandemic on Colorectal Cancer Screening Program.
D'Ovidio V; Lucidi C; Bruno G; Lisi D; Miglioresi L; Bazuro ME
Clin Colorectal Cancer; 2021 Mar; 20(1):e5-e11. PubMed ID: 32868231
[TBL] [Abstract][Full Text] [Related]
26. Nationwide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study.
Olesen TB; Jensen H; Møller H; Jensen JW; Andersen B; Rasmussen M
Elife; 2023 Jan; 12():. PubMed ID: 36695411
[TBL] [Abstract][Full Text] [Related]
27. The Impact of SARS-COV-2 on two Colorectal Cancer screening centres.
Ring É; Conlon C; Kerr H; Cudmore J; King S; O'Grady J; Devlin S; Fitzpatrick P; Leyden J; Cullen G; MacMathúna P; Doherty G; Lahiff C
Ir Med J; 2023 Jan; 116(No.1):3. PubMed ID: 36917018
[TBL] [Abstract][Full Text] [Related]
28. Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
de Jonge L; van de Schootbrugge-Vandermeer HJ; Breekveldt ECH; Spaander MCW; van Vuuren HJ; van Kemenade FJ; Dekker E; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
PLoS One; 2022; 17(6):e0270223. PubMed ID: 35749423
[TBL] [Abstract][Full Text] [Related]
29. Epidemiologic disparities in colon cancer screening and adherence during the COVID-19 pandemic: a retrospective cohort analysis.
Nwankwo EC; Hendrix C; Pollard K; Kallal C; Cruschiel T; Buckhold F; Hachem C
Int J Colorectal Dis; 2022 Apr; 37(4):849-854. PubMed ID: 35275279
[TBL] [Abstract][Full Text] [Related]
30. Impact of social determinants of health on colorectal cancer screening and surveillance in the COVID reopening phase.
Choy AM; Lebwohl B; Krigel A
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):739-743. PubMed ID: 35102113
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
33. Screening Colonoscopy for Colon Cancer in Women during COVID-19 Pandemic.
Bestari MB; Joewono IR
Acta Med Indones; 2021 Jan; 53(1):132-139. PubMed ID: 33818416
[TBL] [Abstract][Full Text] [Related]
34. Colonoscopy screening and surveillance disparities during the COVID-19 pandemic.
Randle HJ; Gorin A; Manem N; Feustel PJ; Antonikowski A; Tadros M
Cancer Epidemiol; 2022 Oct; 80():102212. PubMed ID: 35816937
[TBL] [Abstract][Full Text] [Related]
35. Molecular-based Alternatives for Colorectal Cancer Screening during the COVID-19 Pandemic.
Dockter AG; Angelos GC
Surg Technol Int; 2020 May; 36():143-147. PubMed ID: 32347964
[TBL] [Abstract][Full Text] [Related]
36. Impact of the COVID-19 pandemic on colorectal cancer screening in New York City.
Lee B; Young S; Williams R; Liang PS
J Med Screen; 2023 Jun; 30(2):81-86. PubMed ID: 36164282
[TBL] [Abstract][Full Text] [Related]
37. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
38. Short Term Outcomes of Using Fecal Immunochemical Test for a Pilot Colorectal Cancer Screening Program. A Single Center Study on 3024 Consecutive Patients.
Constantin A; Cazacu I; Ciocârlan M; Constantinescu C; Baltog G; Balahura C; Doraş I; Filip S; Filip G; Panazan I; Piţigoi D; Pirvu V; Turcu F; Copăescu C; Săftoiu A
Chirurgia (Bucur); 2020; 115(4):448-457. PubMed ID: 32876018
[No Abstract] [Full Text] [Related]
39. Resumption of endoscopy in the Galician colorectal cancer screening programme after the COVID-19 lock down: patient safety results.
Peña-Rey I; Almazán R; Rodríguez-Camacho E; Cubiella J
Rev Esp Enferm Dig; 2021 Feb; 113(2):119-121. PubMed ID: 33393333
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 Pandemic Had Minimal Impact on Colonoscopy Completion After Colorectal Cancer Red Flag Sign or Symptoms in US Veterans.
Demb J; Liu L; Bustamante R; Dominitz JA; Earles A; Shah SC; Gawron AJ; Martinez ME; Gupta S
Dig Dis Sci; 2023 Apr; 68(4):1208-1217. PubMed ID: 36169748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
